Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.


Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
May 2019
Historique:
received: 13 08 2018
accepted: 04 01 2019
pubmed: 17 1 2019
medline: 18 12 2019
entrez: 17 1 2019
Statut: ppublish

Résumé

Using the nationwide health insurance claims database, we found that the age-standardized hip fracture incidence rates in Japan indicated significant increase in males but no significant change in females during 2012-2015. The fracture risk in subjects aged 75-84 years indicated decrease in females but no change in males. Nationwide registry data on hip fractures have not yet been established in Japan. Using the newly developed National Database of Health Insurance Claims (NDB), which covers the entire Japanese population, we investigated the incidence rates of hip fractures and the associated regional differences. We also assessed the frequency of osteoporosis prescriptions, bone turnover marker (BTM) level, and bone mineral density (BMD) measurements. The annual numbers of hip fractures, osteoporosis prescriptions, and BTM level and BMD measurements by prefecture from 2012 to 2015 were obtained from NDB data. We calculated the standardized claims-data ratio (SCR) in each prefecture. The age-standardized incidence rates from 2012 to 2015 indicated no significant change in females and significant increase in males (p value for trend; 0.920, 0.002, respectively). The fracture risk decreased in females aged 75-84 years and indicated no increase in females aged 85-89 years during 2012-2015, while the fracture risk indicated no change in males aged 75-84 years and increased in males aged 85-89 years. The frequency of osteoporosis prescriptions, BTM level measurements, and BMD measurements in the general population in the corresponding period increased with statistical or marginal significance in females and males. West-east regional differences were observed in the incidence rates; the highest SCR values in the western prefectures were approximately double the lowest values in the eastern prefectures. The age-standardized hip fracture incidence rates indicated no significant change in females and significant increase in males in Japan from 2012 to 2015.

Identifiants

pubmed: 30648192
doi: 10.1007/s00198-019-04844-8
pii: 10.1007/s00198-019-04844-8
doi:

Substances chimiques

Biomarkers 0
Bone Density Conservation Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

975-983

Références

Osteoporos Int. 1992 Nov;2(6):285-9
pubmed: 1421796
Osteoporos Int. 2004 Nov;15(11):897-902
pubmed: 15490120
Osteoporos Int. 2006;17(4):552-64
pubmed: 16408148
J Nutr. 2006 May;136(5):1323-8
pubmed: 16614424
J Bone Miner Res. 2006 Dec;21(12):1836-8
pubmed: 17002578
Osteoporos Int. 2008 Feb;19(2):243-9
pubmed: 17701364
J Bone Miner Metab. 2008;26(4):400-5
pubmed: 18600408
J Bone Miner Metab. 2010;28(1):60-7
pubmed: 19633809
BMC Public Health. 2010 May 04;10:230
pubmed: 20438644
Clin Interv Aging. 2010 Nov 19;5:355-62
pubmed: 21228901
Osteoporos Int. 2012 Feb;23(2):705-14
pubmed: 21394493
Osteoporos Int. 2011 May;22(5):1277-88
pubmed: 21461721
Osteoporos Int. 2011 Oct;22(10):2575-86
pubmed: 21484361
J Korean Med Sci. 2011 Aug;26(8):1087-92
pubmed: 21860561
Calcif Tissue Int. 2012 Jan;90(1):14-21
pubmed: 22076525
Osteoporos Int. 2012 Oct;23(10):2527-34
pubmed: 22246602
Osteoporos Int. 2012 Sep;23(9):2239-56
pubmed: 22419370
Nihon Eiseigaku Zasshi. 2012 Jan;67(1):56-61
pubmed: 22449824
Arch Osteoporos. 2012;7:3-20
pubmed: 23203733
J Bone Miner Res. 2014 Aug;29(8):1745-55
pubmed: 24644018
Osteoporos Int. 2015 May;26(5):1585-94
pubmed: 25627112
Arch Osteoporos. 2015;10:231
pubmed: 26297076
Osteoporos Int. 2016 May;27(5):1777-84
pubmed: 26733376
Osteoporos Int. 2017 Mar;28(3):811-818
pubmed: 27832325
Medicine (Baltimore). 2017 Apr;96(17):e6725
pubmed: 28445289
Osteoporos Int. 2017 Dec;28(12):3315-3324
pubmed: 29026938
Am J Epidemiol. 1993 May 1;137(9):1001-5
pubmed: 8317445
Osteoporos Int. 1997;7(5):407-13
pubmed: 9425497

Auteurs

J Tamaki (J)

Department of Hygiene and Public Health, Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan. jtamaki@osaka-med.ac.jp.

K Fujimori (K)

Department of Health Administration and Policy, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

S Ikehara (S)

Department of Hygiene and Public Health, Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.

K Kamiya (K)

Department of Hygiene and Public Health, Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.

S Nakatoh (S)

Asahi General Hospital, 477, Tomari, Asahi-machi, Shimo-Shinkawa-gun, Toyama, 939-0798, Japan.

N Okimoto (N)

Okimoto Clinic, 185-4, Kubi, Yutaka-machi, Kure-city, Hiroshima, 734-0304, Japan.

S Ogawa (S)

Department of Geriatric Medicine, Graduate School of Medicine, the University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

S Ishii (S)

Japan Osteoporosis Foundation, 2-14, Oodemma-cho, Nihombashi, Chuo-ku, Tokyo, 103-0011, Japan.

M Iki (M)

Department of Public Health, Kindai University Faculty of Medicine, 377-2, Oono-Higashi, Osaka Sayama city, Osaka, 589-8511, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH